These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 21725702)

  • 21. Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor Signaling.
    Galon-Tilleman H; Yang H; Bednarek MA; Spurlock SM; Paavola KJ; Ko B; To C; Luo J; Tian H; Jermutus L; Grimsby J; Rondinone CM; Konkar A; Kaplan DD
    J Biol Chem; 2017 Feb; 292(5):1925-1933. PubMed ID: 27994053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis.
    Lv D; Li H; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):527-33. PubMed ID: 23588025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APELIN IN HEART FAILURE.
    Marczewski K; Gospodarczyk N; Gospodarczyk A; Widuch M; Tkocz M
    Wiad Lek; 2022; 75(10):2501-2506. PubMed ID: 36472288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apelin secretion and expression of apelin receptors in 3T3-L1 adipocytes are differentially regulated by angiotensin type 1 and type 2 receptors.
    Than A; Tee WT; Chen P
    Mol Cell Endocrinol; 2012 Apr; 351(2):296-305. PubMed ID: 22249006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apelin and energy metabolism.
    Bertrand C; Valet P; Castan-Laurell I
    Front Physiol; 2015; 6():115. PubMed ID: 25914650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of apelin in pathogenesis of cardiovascular diseases and metabolic disorders].
    Cudnoch Jędrzejewska A; Czarzasta K; Gomółka R; Szczepańska Sadowska E
    Kardiol Pol; 2011; 69 Suppl 3():89-93. PubMed ID: 22125210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemerin: a multifaceted adipokine involved in metabolic disorders.
    Helfer G; Wu QF
    J Endocrinol; 2018 Aug; 238(2):R79-R94. PubMed ID: 29848608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apelin and ACE2 in cardiovascular disease.
    Kalea AZ; Batlle D
    Curr Opin Investig Drugs; 2010 Mar; 11(3):273-82. PubMed ID: 20178040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the apelin-APJ pathway and effects on erectile function in a mouse model of vasculogenic erectile dysfunction.
    Kwon MH; Tuvshintur B; Kim WJ; Jin HR; Yin GN; Song KM; Choi MJ; Kwon KD; Batbold D; Ryu JK; Suh JK
    J Sex Med; 2013 Dec; 10(12):2928-41. PubMed ID: 23578329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The apelin/APJ system as a therapeutic target in metabolic diseases.
    Castan-Laurell I; Masri B; Valet P
    Expert Opin Ther Targets; 2019 Mar; 23(3):215-225. PubMed ID: 30570369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target.
    Falcão-Pires I; Leite-Moreira AF
    Rev Port Cardiol; 2005 Oct; 24(10):1263-76. PubMed ID: 16398242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apelin is necessary for the maintenance of insulin sensitivity.
    Yue P; Jin H; Aillaud M; Deng AC; Azuma J; Asagami T; Kundu RK; Reaven GM; Quertermous T; Tsao PS
    Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E59-67. PubMed ID: 19861585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Apelin/Apelin Receptor in Energy Metabolism and Water Homeostasis: A Comprehensive Narrative Review.
    Hu G; Wang Z; Zhang R; Sun W; Chen X
    Front Physiol; 2021; 12():632886. PubMed ID: 33679444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The adipokine apelin and human uterine contractility.
    Hehir MP; Morrison JJ
    Am J Obstet Gynecol; 2012 Apr; 206(4):359.e1-5. PubMed ID: 22360921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apelin, a novel adipokine over-produced in obesity: friend or foe?
    Castan-Laurell I; Boucher J; Dray C; Daviaud D; Guigné C; Valet P
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):7-9. PubMed ID: 16298469
    [No Abstract]   [Full Text] [Related]  

  • 36. Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity?
    Bełtowski J
    Med Sci Monit; 2006 Jun; 12(6):RA112-9. PubMed ID: 16733497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adipokine update - new molecules, new functions].
    Gelsinger C; Tschoner A; Kaser S; Ebenbichler CF
    Wien Med Wochenschr; 2010 Aug; 160(15-16):377-90. PubMed ID: 20812049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diminished metabolic responses to centrally-administered apelin-13 in diet-induced obese rats fed a high-fat diet.
    Clarke KJ; Whitaker KW; Reyes TM
    J Neuroendocrinol; 2009 Feb; 21(2):83-9. PubMed ID: 19076266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of apelin-13 on pancreatic islet beta cell mass and myocardial fatty acid and glucose metabolism of experimental type 2 diabetic rats.
    Feng J; Zhao H; Du M; Wu X
    Peptides; 2019 Apr; 114():1-7. PubMed ID: 30954534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apelin/APJ signaling in hypoxia-related diseases.
    He L; Xu J; Chen L; Li L
    Clin Chim Acta; 2015 Dec; 451(Pt B):191-8. PubMed ID: 26436483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.